Evidence notes
Evidence notes
Articles on biological age, genetics, pharmacogenetics and longevity medicine.
Epigenetic ageing
- Evidence note · 16 August 2026
The New Science of Healthy Ageing: The Breakthroughs That Could Redefine Longevity Medicine
Scientists increasingly view ageing not as one single mechanism, but as an interconnected network of biological changes involving genomic instability, epigenetic alteration, mitochondrial dysfunction, impaired cellular recycling, cellular senescence, chronic inflammation, altered nutrient sensing, stem-cell exhaustion and changes in communication between cells and tissues. - Evidence note · 13 July 2026
If DNA Determines Our Future, Why Do Identical Twins Age Differently?
DNA may provide the blueprint—but it doesn't determine your destiny. Discover what identical twin studies reveal about epigenetics, biological resilience, and why the future of longevity medicine depends on measuring biology in motion, not genetics alone. - Evidence note · 11 July 2026
Why Conventional DNA Methylation Clocks Can Miss Important Biology
New research suggests traditional epigenetic clocks may miss early biological dysregulation. Learn how measuring epigenetic noise changes longevity diagnostics. - News · 31 May 2026
New in SystemAge™: Gender-Specific Biological Aging Analysis
Did you know that men and women age differently at the biological level? Research consistently shows differences in lifespan, cardiovascular aging, immune function, hormonal aging, brain health, and epigenetic aging trajectories between males and females. That's why we're excited to introduce a major update to the epigenetic biological age test: your report will now be tailored to the sex indicated in your account profile. - News · 17 February 2026
Aging is not inevitable decline. It is measurable. Manageable. And in many systems — reversible.
Aging is not inevitable decline. It is measurable. Manageable. And in many systems — reversible. - News · 19 January 2026
Biological Age, Longevity & Preventive Health: Why Most Aging Tests Miss the Point — and How SystemAge™ Measures What Actually Matters
Discover why most biological age tests fail — and how the epigenetic biological age test measures organ-level aging, biological entropy, and early disease risk for longevity, biohacking, and preventive healthcare. - News · 3 November 2025
Age Reversal Technology: Top 5 Breakthroughs
Age reversal is no longer science fiction. Advances in epigenetics now make it possible to measure how your body is aging at the cellular and organ-system level—and to verify whether longevity interventions are actually working.
Genetics and pharmacogenetics
- Evidence note · 3 September 2026
Pharmacogenetic Testing and Personalised Prescribing
Discover how pharmacogenetic testing can help clinicians understand genetic differences in medication response and support more personalised prescribing. - Evidence note · 24 August 2026
How to Read Pharmacogenetic DNA Test Results | CYP2D6
Learn how pharmacogenetic testing translates DNA into insights on drug metabolism, medication response and more personalised prescribing. - News · 12 January 2026
Pharmacogenetic DNA test explained: Part II
Pharmacogenetic DNA testing explains why people respond differently to the same medication—and how treatment can be tailored more safely and effectively. - Evidence note · 1 January 2026
Pharmacogenetics in practice
Pharmacogenetics is transforming clinical practice by enabling safer, more effective, and more cost-efficient prescribing. By tailoring treatment based on CYP2C19 genetic variants, clinicians can optimise therapy, reduce bleeding risk, and avoid unnecessary use of expensive medications—highlighting the real-world value of pharmacogenetics in modern healthcare. - News · 3 November 2025
Lactose intolerance: test your own predisposition
Lactose intolerance can cause symptoms like bloating, stomach pain, and fatigue—but its underlying cause isn’t always the same. This article explains what lactose intolerance is, the difference between genetic (primary) and acquired (secondary) forms, and how different testing methods compare.
Immune ageing and glycan biology
Clinical practice
- Evidence note · 13 October 2026
Multi-Omics in Precision & Preventive Medicine: From Molecular Insights to Better Health Outcomes
How integrating genomics, epigenomics, proteomics, metabolomics and clinical biomarkers may support personalised prevention, health optimisation and healthy ageing. - News · 19 August 2026
How to Add Biological Age Testing to Longevity Clinics
Learn how to integrate biological age testing into longevity clinics to support personalised interventions, longitudinal tracking and measurable outcomes. - News · 5 July 2026
Biological Age Testing in Preventive Care for 2026
Discover how biological age testing is transforming preventive care in 2026. Learn about epigenetics, biomarkers of aging, clinical integration, and test accuracy. - News · 1 December 2025
Biological Age Tests: Choosing the Right Kit
Biological Age Tests: Choosing the Right Kit. Chronological age tells you how long you’ve lived—but biological age reveals how well your body is actually ageing. - News · 8 October 2025
Translating pharmacogenetic knowledge into clinical care
Erasmus MC integrates pharmacogenetic data into clinical care using a pharmacogenetic platform, enabling secure reporting and personalised pharmacotherapy.
Women's health
Company and events
- News · 23 September 2026
From Wrinkles to Resilience: What Skin Can Really Tell Us About Ageing
BioAgeDiagnostics co-founder Bettina van Wylich-Muxoll joins an INNOCOS panel exploring skin resilience, mitochondrial function and evidence in longevity science. - News · 23 September 2026
BioAgeDiagnostics Named Finalist in the 2026 Beauty & Longevity CHOICE Awards
BioAgeDiagnostics has been named an official finalist in the 2026 Beauty & Longevity CHOICE Awards, in Diagnostics, Wearables & Deep-Tech Platforms. - News · 28 July 2026
Leading Longevity Physician Dr. Stuart M. Diamond Joins BioAgeDiagnostics Medical Advisory Board
Excited to welcome Dr. Stuart M. Diamond to BioAgeDiagnostics as Medical Advisor. Together we're advancing precision longevity medicine. - News · 11 April 2026
The Longevity Economy: From Trend to Trillion-Dollar Infrastructure Shift
The longevity economy is emerging as a multi-trillion-dollar global market, driven by advances in diagnostics, AI, regenerative medicine, and preventive healthcare. As populations age, industries and governments are shifting toward healthspan optimisation—transforming aging from a biological inevitability into a measurable, manageable, and economically critical driver of future growth. - News · 8 March 2026
NADclinic and BioAgeDiagnostics Collaborate to Establish a New Standard in Data-Driven Longevity Medicine
A new collaboration between NADclinic and BioAgeDiagnostics integrates biological age testing with NAD+ therapeutics to support data-driven precision longevity medicine. - News · 5 February 2026
Meet us at WHX Lab Expo
We are excited to announce that BioAgeDiagnostics will be attending the World Health Expo (WHX) in Dubai from 10–13 February 2026. At WHX, we will be showcasing how precision diagnostics and system-level biological age measurement can support the next generation of preventive, personalised, and performance-driven healthcare.
Contact
Thirty minutes, and you will know whether this fits your clinic.
Tell us how your clinic works today and which patients you see. We will go through the portfolio, what can be offered in your market, and what your team would need from us.